Analyst Consensus ?
ConsensusBuy45 ratings
Bullish2862.2%
Neutral1533.3%
Bearish24.5%
FN2 Earnings Intelligence
HCA Healthcare, Inc. analyst ratings
HCA Healthcare, Inc. (HCA) analyst consensus, price targets, and firm-level rating history from FN2 Research.
Analyst 52W Price Targets
$442.79Current
$224Low
$400.65Average
$579High
Latest persisted target per named analyst; persisted current price from FN2's market snapshot as of Oct 27, 2026. Not an FN2 forecast.
Firm-level rating actions
FMP grade actions identify the grading firm, not a named analyst.
| Firm | Rating | Prior rating | Action | Date |
|---|---|---|---|---|
| TD Cowen | Buy | Buy | Maintain | Oct 12, 2026 |
| RBC Capital | Outperform | Outperform | Maintain | Oct 7, 2026 |
| Leerink Partners | Outperform | Outperform | Maintain | Sep 18, 2026 |
| JP Morgan | Neutral | Neutral | Maintain | Aug 20, 2026 |
| Wells Fargo | Equal Weight | Equal Weight | Maintain | Aug 3, 2026 |
| Mizuho | Outperform | Outperform | Maintain | Jul 28, 2026 |
| Goldman Sachs | Buy | Buy | Maintain | Jul 28, 2026 |
| UBS | Buy | Buy | Maintain | Jul 27, 2026 |
| Truist Securities | Buy | Buy | Maintain | Jul 27, 2026 |
| Oppenheimer | Outperform | Outperform | Maintain | Jul 27, 2026 |
| Morgan Stanley | Underweight | Underweight | Maintain | Jul 27, 2026 |
| Keybanc | Overweight | Overweight | Maintain | Jul 27, 2026 |
| Barclays | Equal Weight | Equal Weight | Maintain | Jul 27, 2026 |
| Baird | Neutral | Neutral | Maintain | Jul 27, 2026 |
| Cantor Fitzgerald | Overweight | Overweight | Maintain | Jul 7, 2026 |
| Bernstein | Market Perform | Market Perform | Maintain | Jun 4, 2026 |
| Stephens & Co. | Overweight | Overweight | Maintain | Apr 27, 2026 |
| Argus Research | Buy | Buy | Maintain | Feb 6, 2026 |
| Jefferies | Buy | Buy | Maintain | Jan 28, 2026 |
| Deutsche Bank | Buy | Buy | Maintain | Jan 28, 2026 |
| B of A Securities | Neutral | Neutral | Maintain | Oct 27, 2025 |
| Wolfe Research | Peer Perform | Outperform | Downgrade | Jul 28, 2025 |
| Raymond James | Market Perform | Outperform | Downgrade | Nov 22, 2024 |
| Citigroup | Buy | Buy | Maintain | Oct 25, 2023 |
| Credit Suisse | Outperform | Outperform | Maintain | Jul 28, 2023 |
| Loop Capital | Buy | Buy | Maintain | Apr 24, 2023 |
| Cowen & Co. | Outperform | Outperform | Maintain | Jan 30, 2023 |
| SVB Leerink | Outperform | Outperform | Maintain | Dec 16, 2022 |
| BMO Capital | Underperform | Market Perform | Downgrade | Jul 6, 2022 |
| Seaport Global | Buy | Buy | Maintain | Jul 9, 2021 |
| Piper Sandler | Neutral | Neutral | Maintain | Nov 25, 2020 |
| SunTrust Robinson Humphrey | Buy | Buy | Maintain | Apr 22, 2020 |
| Bank of America | Buy | Neutral | Upgrade | Dec 6, 2019 |
| Argus | Buy | Buy | Maintain | Nov 6, 2018 |
| Leerink Swann | Outperform | Outperform | Maintain | Sep 4, 2018 |
| PiperJaffray | Neutral | Overweight | Downgrade | Jan 3, 2018 |
| William Blair | Perform | Market Perform | Maintain | Nov 21, 2017 |
| Avondale Partners | Market Perform | Market Outperform | Downgrade | Nov 9, 2016 |
| Evercore ISI Group | Hold | Hold | Maintain | Sep 23, 2016 |
| Longbow Research | Market Perform | Outperform | Downgrade | Jan 6, 2016 |
| Wedbush | Outperform | Outperform | Maintain | Jun 10, 2015 |
| Sterne Agee | Buy | Buy | Maintain | Dec 18, 2014 |
| Monness Crespi Hardt | Buy | Buy | Maintain | Mar 31, 2014 |
| Macquarie | Neutral | Outperform | Downgrade | Mar 12, 2013 |
| Imperial Capital | Outperform | Outperform | Maintain | Jan 17, 2013 |
Named analyst price targets
Upside is calculated against the persisted current price $442.79. FMP does not supply a rating on these named-analyst rows.
| Firm | Analyst | 52W target | Price when posted | Upside | Date |
|---|---|---|---|---|---|
| RBC Capital | Analyst unavailable | $496 | $438.46 | +12.0% | Oct 7, 2026 |
| BMO Capital | Analyst unavailable | $495 | $438.12 | +11.8% | Sep 22, 2026 |
| Goldman Sachs | Analyst unavailable | $485 | $389.62 | +9.5% | Jul 28, 2026 |
| UBS | Analyst unavailable | $579 | $390.7 | +30.8% | Jul 27, 2026 |
| Deutsche Bank | Analyst unavailable | $476 | $387.41 | +7.5% | Jul 27, 2026 |
| Morgan Stanley | Analyst unavailable | $380 | $388.48 | -14.2% | Jul 27, 2026 |
| Oppenheimer | Michael Wiederhorn | $485 | $388.93 | +9.5% | Jul 27, 2026 |
| Robert W. Baird | Analyst unavailable | $393 | $382.19 | -11.2% | Jul 27, 2026 |
| Barclays | Analyst unavailable | $387 | $382.19 | -12.6% | Jul 27, 2026 |
| KeyBanc | Analyst unavailable | $435 | $382.19 | -1.8% | Jul 27, 2026 |
| Wells Fargo | Stephen Baxter | $369 | $371.18 | -16.7% | Jul 20, 2026 |
| Barclays | Analyst unavailable | $402 | $378.85 | -9.2% | Jul 16, 2026 |
| RBC Capital | Analyst unavailable | $435 | $363.6 | -1.8% | Jul 15, 2026 |
| Jefferies | Analyst unavailable | $450 | $363.6 | +1.6% | Jul 14, 2026 |
| Wells Fargo | Analyst unavailable | $428 | $406.59 | -3.3% | Jul 13, 2026 |
| Barclays | Analyst unavailable | $427 | $423.11 | -3.6% | Jul 8, 2026 |
| Raymond James | Sarah James | $528 | $424.8 | +19.2% | Jul 7, 2026 |
| Cantor Fitzgerald | Analyst unavailable | $525 | $417.07 | +18.6% | Jul 7, 2026 |
| Truist Financial | Analyst unavailable | $413 | $367.69 | -6.7% | Jun 4, 2026 |
| Bernstein | Analyst unavailable | $413 | $363.23 | -6.7% | Jun 4, 2026 |
| Stephens | Analyst unavailable | $530 | $444.76 | +19.7% | Apr 27, 2026 |
| Truist Financial | Analyst unavailable | $535 | $432.46 | +20.8% | Apr 27, 2026 |
| Oppenheimer | Analyst unavailable | $520 | $432.46 | +17.4% | Apr 27, 2026 |
| RBC Capital | Analyst unavailable | $534 | $432.46 | +20.6% | Apr 27, 2026 |
| Wells Fargo | Analyst unavailable | $436 | $432.46 | -1.5% | Apr 27, 2026 |
| KeyBanc | Analyst unavailable | $510 | $432.46 | +15.2% | Apr 27, 2026 |
| Barclays | Analyst unavailable | $496 | $432.46 | +12.0% | Apr 27, 2026 |
| Jefferies | Analyst unavailable | $525 | $432.46 | +18.6% | Apr 24, 2026 |
| UBS | Analyst unavailable | $635 | $532.3 | +43.4% | Feb 23, 2026 |
| Bernstein | Analyst unavailable | $541 | $501.69 | +22.2% | Feb 9, 2026 |
| Mizuho Securities | Analyst unavailable | $540 | $488.27 | +22.0% | Feb 2, 2026 |
| Wells Fargo | Analyst unavailable | $481 | $482.53 | +8.6% | Jan 30, 2026 |
| RBC Capital | Analyst unavailable | $555 | $483.16 | +25.3% | Jan 28, 2026 |
| KeyBanc | Analyst unavailable | $503 | $483.76 | +13.6% | Jan 28, 2026 |
| UBS | Analyst unavailable | $598 | $487.53 | +35.1% | Jan 28, 2026 |
| Oppenheimer | Analyst unavailable | $540 | $505.84 | +22.0% | Jan 28, 2026 |
| UBS | Analyst unavailable | $588 | $505.84 | +32.8% | Jan 28, 2026 |
| KeyBanc | Analyst unavailable | $550 | $505.84 | +24.2% | Jan 28, 2026 |
| Barclays | Andrew Mok | $551 | $505.84 | +24.4% | Jan 28, 2026 |
| KeyBanc | Analyst unavailable | $500 | $465.44 | +12.9% | Jan 22, 2026 |
| Wells Fargo | Stephen Baxter | $452 | $483.6 | +2.1% | Jan 7, 2026 |
| Bernstein | Analyst unavailable | $503 | $479.53 | +13.6% | Jan 6, 2026 |
| Mizuho Securities | Analyst unavailable | $520 | $471.85 | +17.4% | Dec 18, 2025 |
| Truist Financial | Analyst unavailable | $495 | $447.04 | +11.8% | Oct 27, 2025 |
| Stephens | Raj Kumar | $500 | $447.04 | +12.9% | Oct 27, 2025 |
| RBC Capital | Ben Hendrix | $482 | $447.04 | +8.9% | Oct 27, 2025 |
| Barclays | Analyst unavailable | $494 | $454.84 | +11.6% | Oct 27, 2025 |
| UBS | Analyst unavailable | $525 | $454.84 | +18.6% | Oct 27, 2025 |
| Morgan Stanley | Analyst unavailable | $425 | $452.07 | -4.0% | Oct 27, 2025 |
| Goldman Sachs | Scott Fidel | $520 | $452.23 | +17.4% | Oct 27, 2025 |
| Raymond James | Sarah James | $525 | $454.58 | +18.6% | Oct 27, 2025 |
| Oppenheimer | Analyst unavailable | $500 | $454.03 | +12.9% | Oct 27, 2025 |
| Mizuho Securities | Analyst unavailable | $505 | $453.92 | +14.0% | Oct 27, 2025 |
| Bernstein | Analyst unavailable | $417 | $451.02 | -5.8% | Oct 27, 2025 |
| Mizuho Securities | Analyst unavailable | $475 | $419.6 | +7.3% | Oct 17, 2025 |
| Truist Financial | Analyst unavailable | $460 | $412.66 | +3.9% | Oct 14, 2025 |
| UBS | Analyst unavailable | $495 | $415.65 | +11.8% | Oct 14, 2025 |
| Goldman Sachs | Analyst unavailable | $470 | $410.68 | +6.1% | Oct 14, 2025 |
| UBS | Analyst unavailable | $465 | $437.57 | +5.0% | Oct 8, 2025 |
| Wells Fargo | Analyst unavailable | $412 | $433.55 | -7.0% | Oct 7, 2025 |
| Barclays | Analyst unavailable | $445 | $401.1 | +0.5% | Sep 18, 2025 |
| RBC Capital | Ben Hendrix | $401 | $334.29 | -9.4% | Jul 28, 2025 |
| Morgan Stanley | Craig Hettenbach | $410 | $373.01 | -7.4% | Jun 9, 2025 |
| Barclays | Andrew Mok | $416 | $382.16 | -6.1% | Jun 2, 2025 |
| KeyBanc | Matthew Gillmor | $370 | $308.21 | -16.4% | Jan 7, 2025 |
| Oppenheimer | Michael Wiederhorn | $400 | $359.07 | -9.7% | Oct 28, 2024 |
| KeyBanc | Matthew Gillmor | $420 | $359.07 | -5.1% | Oct 28, 2024 |
| Mizuho Securities | Ann Hynes | $425 | $359.16 | -4.0% | Oct 28, 2024 |
| KeyBanc | Matthew Gillmor | $475 | $387.25 | +7.3% | Oct 10, 2024 |
| Deutsche Bank | Pito Chickering | $441 | $406.01 | -0.4% | Oct 1, 2024 |
| Truist Financial | David MacDonald | $430 | $373.77 | -2.9% | Aug 19, 2024 |
| Deutsche Bank | Pito Chickering | $375 | $335.04 | -15.3% | Jun 28, 2024 |
| Jefferies | Brian Tanquilut | $390 | $336.82 | -11.9% | Jun 6, 2024 |
| RBC Capital | Ben Hendrix | $329 | $311.07 | -25.7% | Apr 29, 2024 |
| Oppenheimer | Michael Wiederhorn | $345 | $306.69 | -22.1% | Apr 29, 2024 |
| Deutsche Bank | Pito Chickering | $359 | $327.25 | -18.9% | Apr 12, 2024 |
| Mizuho Securities | Ann Hynes | $298 | $285.91 | -32.7% | Apr 24, 2023 |
| Goldman Sachs | Analyst unavailable | $296 | $257.09 | -33.2% | Feb 8, 2023 |
| UBS | Analyst unavailable | $296 | $257.85 | -33.2% | Jan 13, 2023 |
| Wells Fargo | Analyst unavailable | $243 | $243.21 | -45.1% | Jan 3, 2023 |
| Leerink Partners | Analyst unavailable | $286 | $239.7 | -35.4% | Dec 16, 2022 |
| Goldman Sachs | Analyst unavailable | $265 | $241.35 | -40.2% | Dec 12, 2022 |
| Raymond James | Analyst unavailable | $250 | $208.97 | -43.5% | Sep 16, 2022 |
| Leerink Partners | Analyst unavailable | $259 | $210.25 | -41.5% | Aug 24, 2022 |
| Mizuho Securities | Ann Hynes | $230 | $213.47 | -48.1% | Aug 16, 2022 |
| Wells Fargo | Analyst unavailable | $199 | $204.66 | -55.1% | Jul 28, 2022 |
| Raymond James | Analyst unavailable | $230 | $198.63 | -48.1% | Jul 26, 2022 |
| RBC Capital | Analyst unavailable | $249 | $198.53 | -43.8% | Jul 25, 2022 |
| Credit Suisse | Analyst unavailable | $250 | $202.87 | -43.5% | Jul 25, 2022 |
| Truist Financial | Analyst unavailable | $240 | $202.03 | -45.8% | Jul 25, 2022 |
| Leerink Partners | Analyst unavailable | $240 | $202.03 | -45.8% | Jul 25, 2022 |
| Leerink Partners | Analyst unavailable | $212 | $167.49 | -52.1% | Jul 15, 2022 |
| Goldman Sachs | Analyst unavailable | $233 | $170.02 | -47.4% | Jul 12, 2022 |
| Raymond James | Analyst unavailable | $220 | $172.6 | -50.3% | Jul 11, 2022 |
| Deutsche Bank | Analyst unavailable | $200 | $172.76 | -54.8% | Jul 7, 2022 |
| Mizuho Securities | Analyst unavailable | $210 | $168.06 | -52.6% | Jul 1, 2022 |
| RBC Capital | Analyst unavailable | $256 | $173.1 | -42.2% | Jun 21, 2022 |
| Loop Capital Markets | Joseph France | $240 | $171.56 | -45.8% | Jun 16, 2022 |
| Mizuho Securities | Analyst unavailable | $260 | $215.7 | -41.3% | May 3, 2022 |
| BMO Capital | Matt Borsch | $240 | $219.06 | -45.8% | Apr 28, 2022 |
| UBS | Analyst unavailable | $241 | $210.9 | -45.6% | Apr 26, 2022 |
| Raymond James | Analyst unavailable | $245 | $210.5 | -44.7% | Apr 26, 2022 |
| Truist Financial | Analyst unavailable | $250 | $210.56 | -43.5% | Apr 25, 2022 |
| Wells Fargo | Analyst unavailable | $227 | $211.94 | -48.7% | Apr 25, 2022 |
| Credit Suisse | Analyst unavailable | $260 | $208.7 | -41.3% | Apr 25, 2022 |
| Leerink Partners | Analyst unavailable | $273 | $210.64 | -38.3% | Apr 25, 2022 |
| Citigroup | Analyst unavailable | $254 | $210.64 | -42.6% | Apr 25, 2022 |
| RBC Capital | Analyst unavailable | $267 | $210.64 | -39.7% | Apr 25, 2022 |
| Wells Fargo | Steve Baxter | $227 | $210.5 | -48.7% | Apr 25, 2022 |
| Barclays | Sarah James | $256 | $210.64 | -42.2% | Apr 22, 2022 |
| Mizuho Securities | Ann Hynes | $290 | $210.64 | -34.5% | Apr 22, 2022 |
| Truist Financial | David S Macdonald | $310 | $258.43 | -30.0% | Jan 5, 2022 |
| Jefferies | Brian Tanquilut | $310 | $259.72 | -30.0% | Jan 4, 2022 |
| J.P. Morgan | Lisa Gill | $270 | $246.51 | -39.0% | Dec 21, 2021 |
| Mizuho Securities | Ann Hynes | $290 | $245.1 | -34.5% | Dec 20, 2021 |
| Raymond James | John Ransom | $300 | $240.42 | -32.2% | Oct 26, 2021 |
| Oppenheimer | Michael Wiederhorn | $290 | $240.83 | -34.5% | Oct 25, 2021 |
| Deutsche Bank | Pito Chickering | $306 | $240.83 | -30.9% | Oct 25, 2021 |
| Barclays | Sarah James | $275 | $244.85 | -37.9% | Aug 16, 2021 |
| Argus Research | Jasper Hellweg | $275 | $249.51 | -37.9% | Aug 2, 2021 |
| Wolfe Research | Justin Lake | $224 | $206.85 | -49.4% | Jun 21, 2021 |
Track every rating change on HCA the moment it posts. Free to start.
Start freeGet the HCA recap when the next report posts
One email per quarter with the scorecard, the market reaction and what changed on the call. No account needed.